TABLE 2.

Comparison of platelet activation biomarker variation.

Platelet activation biomarkers	Dabigatran (n = 33)	Rivaroxaban (n = 72)	p Value
ΔTAT	13.52 ± 4.17	2.04 ± 1.88	0.001*
ΔP-selectin	14.40 ± 2.16	4.79 ± 1.42	0.031*
ΔvWF	63.82 ± 11.95	19.57 ± 6.27	0.007*
ΔCD40L	30.88 ± 13.83	18.02 ± 9.23	0.543

Intraindividual plasma platelet activation biomarkers variation followed by 3-month post-anticoagulation with dabigatran or rivaroxaban. Δ referred to variation of platelet activation biomarkers; TAT, thrombin–antithrombin complex; vWF, von Willebrand disease.